C4 Therapeutics
Balance Sheet

Last updated:

The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has C4 Therapeutics's balance sheet done over the years? Its assets were worth $376,451,000 last year, which is less than in the previous period. 35% of C4 Therapeutics’s total assets is currently financed by debt. Its liabilities reached the amount of $130,336,999, which means an decrease by -8% compared compared to last year.

Debt to Assets

C4 Therapeutics, Inc. (NASDAQ:CCCC): Debt to assets
2018 146491000 226.24M 154.44%
2019 118260000 230.22M 194.68%
2020 400138000 119.34M 29.83%
2021 506765000 117.15M 23.12%
2022 430840000 141.60M 32.87%
2023 376451000 130.33M 34.62%

CCCC Balance Sheet (2018 – 2023)

2023 2022 2021 2020 2019 2018
Assets
Current assets:
Cash and cash equivalents
126.59M29.75M76.12M181.72M90.54M36.31M
Short term investments
127.09M246.39M233.15M189.96M00
Net receivables
11.79M1.47M5.71M4.48M4.62M86.43M
Inventory
0-60.96M0010
Other current assets
5.70M9.93M10.69M4.83M1.59M781K
Total current assets
271.18M287.55M325.68M381.00M96.76M123.53M
Non-current assets:
Property, Plant and Equipment
71.08M77.51M35.05M16.55M18.91M20.38M
Goodwill
000000
Intangible assets
000000
Long term investments
28.00M60.96M142.2M2.57M2.57M0
Other non-current assets
6.16M4.80M3.82M002.57M
Total non-current assets
105.26M143.28M181.07M19.12M21.49M22.96M
Total assets
376.45M430.84M506.76M400.13M118.26M146.49M
Liabilities
Current liabilities:
Accounts payable
Deferred revenue
15.47M33.51M31.8M27.60M20.70M19.10M
Short term debt
10.43M6.98M1.33M1.04M880K734K
Total current liabilities
42.76M44.54M51.24M43.85M33.64M23.94M
Non-current liabilities:
Long term debt
131.51M80.16M41.54M21.87M12.86M13.74M
Deferred tax
000000
Other non-current liabilities
-65.75M-9.19M-10.76M-10.05M110.99M124.74M
Total non-current liabilities
87.57M97.06M65.91M75.49M196.58M202.29M
Total liabilities
130.33M141.60M117.15M119.34M230.22M226.24M
Data sourceData sourceData sourceData source